(101 days)
Politzer Bag
No
The summary describes a mechanical device for ventilating the middle ear and does not mention any AI or ML components or capabilities.
Yes
The device is indicated for the treatment of various middle ear pressure problems, including fluid accumulation, temporary hearing loss, and ear pain, directly addressing health conditions.
No
Explanation: The device description and intended use clearly state that the EarPopper is a treatment for negative middle ear pressure, not a diagnostic tool. It provides a method of ventilating the middle ear to equalize pressure and manage symptoms, rather than identifying or diagnosing a condition.
No
The device description clearly indicates a physical device ("The EarPopper is a non-surgical, non-drug related treatment...") that provides a method of increasing air pressure, which requires hardware components. The summary does not mention any software-only aspects.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- EarPopper Function: The EarPopper is a device that physically interacts with the body (nose, eustachian tube, middle ear) to equalize pressure. It does not analyze any biological specimens.
- Intended Use: The intended use is for the treatment of negative middle ear pressure, not for analyzing samples to diagnose a condition.
The EarPopper is a therapeutic device, not a diagnostic one.
N/A
Intended Use / Indications for Use
The EarPopper is indicated for the treatment of negative middle ear pressure. Negative middle ear pressure can lead to fluid accumulation in the middle ear, impaired hearing and hearing loss. The EarPopper provides a method of ventilating the middle ear by momentarily increasing the air pressure in the nose and the eustachian tube. Equalizing the pressure can prevent the accumulation of fluid and prevent hearing loss.
Product codes (comma separated list FDA assigned to the subject device)
MJV
Device Description
The EarPopper is a non-surgical, non-drug related treatment for middle ear pressure problems such as:
- Middle ear fluid (Otitis Media with Effusion)
- Eustachian Tube Dysfunction
- Temporary hearing loss
- Ear pain and pressure caused by air travel.
- Ear fullness caused by colds, allergies, sinusitis
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
middle ear, nose, eustachian tube
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Performed at home by patient on his own, or under adult supervision
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Politzer Bag
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
N/A
0
MAR 14 2 :: 3
510(k) SUMMARY
Company Name and Address: Micromedics Inc. 1270 Eagan Industrial Road St. Paul, MN. 55121-1385
Image /page/0/Picture/4 description: The image shows the logo for Micromedics. The logo consists of a graphic of three curved lines emanating from a solid circle, resembling sound waves or a stylized ear. Below the graphic is the word "Micromedics" in a bold, sans-serif font. Underneath "Micromedics" are the words "Innovative Surgical Products" in a smaller, less bold font.
toll free US: 1-8 1270 Eagan Industrial Road . St. Paul, MN 55121
Contact Person Tom Lopac Manager of Quality & Regulatory Affairs, Micromedics Inc. Telephone: 651-452-1977 Fax: 651-452-1787
DATE PREPARED: 11-30-07
TRADE NAME: COMMON NAME: PRO CODE:
EarPopper Device, inflation, middle ear MJV
DESCRIPTION of the DEVICE:
The EarPopper is a non-surgical, non-drug related treatment for middle ear pressure problems such as:
- . Middle ear fluid (Otitis Media with Effusion)
- Eustachian Tube Dysfunction
- . Temporary hearing loss
- Ear pain and pressure caused by air travel .
- . Ear fullness caused by colds, allergies, sinusitis
INDICATIONS FOR USE:
The EarPopper is indicated for the treatment of negative middle ear pressure. Negative middle ear pressure can lead to fluid accumulation in the middle ear, impaired hearing and hearing loss. The EarPopper provides a method of ventilating the middle ear by momentarily increasing the air pressure in the nose and the eustachian tube. Equalizing the pressure can prevent the accumulation of fluid and prevent hearing loss.
SUBSTANTIALLY EQUIVALENT TO:
Earclear (K951596) Arisil Medical Otovent (K920840) ABIGO Medical Co. Politzer Bag
1
SUMMARY of EQUIVALENCE:
Characteristic | EarPopper | Earclear K951596 | Politzer Bag | Otovent K920840 |
---|---|---|---|---|
Intended use | The EarPopper is | |||
indicated for the | ||||
treatment of negative | ||||
middle ear pressure. | ||||
Negative middle ear | ||||
pressure can lead to fluid | ||||
accumulation in the | ||||
middle ear, impaired | ||||
hearing and hearing loss. | ||||
The EarPopper provides a | ||||
method of ventilating the | ||||
middle ear by | ||||
momentarily increasing | ||||
the air pressure in the | ||||
nose and the eustachian | ||||
tube. Equalizing the | ||||
pressure can prevent the | ||||
accumulation of fluid and | ||||
prevent hearing loss. | The Earclear is indicated | |||
for the treatment of | ||||
negative middle ear | ||||
pressure. Negative middle | ||||
ear pressure can lead to | ||||
fluid accumulation in the | ||||
middle ear, impaired | ||||
hearing and hearing loss. | ||||
The Earclear provides a | ||||
method of ventilating the | ||||
middle ear by forcing air | ||||
pressure through the nose | ||||
and the Eustachian tube | ||||
into the middle ear. | ||||
Equalizing the pressure | ||||
can prevent the | ||||
accumulation of fluid and | ||||
prevent hearing loss. | Treatment of negative | |||
middle ear pressure | Treatment of negative | |||
middle ear pressure | ||||
Patient Use | Performed at home by | |||
patient on his own, or | ||||
under adult supervision | Performed at home by | |||
patient on his own, or | ||||
under adult supervision | Performed at home by | |||
patient on his own, or | ||||
under adult supervision, | ||||
but typically requires a | ||||
second person to | ||||
deliver the air pressure | Performed at home by | |||
patient on his own, or | ||||
under adult | ||||
supervision | ||||
Principle of | ||||
Operation | Ventilating the middle ear | |||
by momentarily | ||||
increasing the air pressure | ||||
in the nose and the | ||||
eustachian tube | Ventilation of the middle | |||
ear by forcing air under | ||||
pressure through the nose | ||||
and the eustachian tube | ||||
into the middle ear | Ventilation of the | |||
middle ear by forcing | ||||
air under pressure | ||||
through the nose and | ||||
the eustachian tube into | ||||
the middle ear | Ventilation of the | |||
middle ear by forcing | ||||
air under pressure | ||||
through the nose and | ||||
the eustachian tube | ||||
into the middle ear | ||||
Mode of | ||||
Operation | Non-sterile, battery | |||
powered device is held | ||||
against the nostril, | ||||
delivering continuous air | ||||
pressure via an air pump | Non-sterile, battery | |||
powered device is held | ||||
against the nostril, | ||||
delivering continuous air | ||||
pressure via an air pump | Non-sterile, manual | |||
device is held against | ||||
the nostril, delivering | ||||
varying amount of air | ||||
pressure via the | ||||
compression of a bulb | ||||
(bag) | Non-sterile, manual | |||
device is held against | ||||
the nostril, delivering | ||||
varying amount of air | ||||
pressure via the | ||||
deflation of the | ||||
patient-inflated | ||||
balloon. | ||||
Major | ||||
Components | Plastic (ABS / | |||
Polycarbonate / | ||||
Polystyrene) nosepiece | ||||
mounted to a plastic case, | ||||
housing an air pump, | ||||
batteries and a printed | ||||
circuit board | Plastic (PVC/ABS/PEI) | |||
nosepiece mounted to a | ||||
plastic case, housing an air | ||||
pump, batteries and a | ||||
printed circuit board | Plastic or glass | |||
nosepiece mounted to a | ||||
rubber tube which is | ||||
connected to a rubber | ||||
bulb (bag) | Plastic (PVC) | |||
nosepiece mounted to | ||||
a latex balloon | ||||
Air Pressure | Continuous, controlled to | |||
3 PSI with air flow of 0.6 | ||||
L/minute on low setting | ||||
and 6 PSI with air flow of | ||||
1.3 L/minute on high | ||||
setting | Continuous, controlled to | |||
1.5 PSI on low setting and | ||||
3 PSI on high setting | Varying, uncontrolled | |||
range: 1.5 to 5.9 PSI | ||||
reported by Politzer, 5.2 | ||||
PSI reported by | ||||
Schwartz, 10 to 30 PSI | Varying, | |||
uncontrolled, value | ||||
not specified in the | ||||
product literature |
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol on the right. To the left of the bird symbol, the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is arranged in a circular fashion.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Micromedics, Inc. c/o Tom Lopac Quality Manager 1270 Eagan Industrial Road Suite 120 St. Paul. MN 55121-1385
MAR 1 4 2008
Re: K073401
Trade/Device Name: EarPopper Regulation Number: Unclassified Product Code: MJV Dated: February 11, 2008 Received: February 15, 2008
Dear Mr. Lopac:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Maling B. Eeplata, ud
Malvina B. Eydelman, M.I Director Division of Ophthalmic and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
K07340
STATEMENT OF INDICATIONS FOR USE
510(k) Number (if known):
Device Name: EarPopper
Indications for Use:
The EarPopper is indicated for the treatment of negative middle ear pressure. Negative middle ear pressure can lead to fluid accumulation in the middle ear, impaired hearing and hearing loss. The EarPopper provides a method of ventilating the middle ear by momentarily increasing the air pressure in the nose and the eustachian tube. Equalizing the pressure can prevent the accumulation of fluid and prevent hearing loss.
Prescription Use: X (Per 21 CFT 801.109)
OR
Over-The-Counter
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Laura Bohm
Division Sian-Off vision of Ophthalmic f Nose and Throat Devis
510(k) Number K073401
Page 4-1